ZVSA

ZyVersa Therapeutics
ZVSA

Overview Fund Activity
Delisted

ZVSA was delisted on the 16th of July, 2025.

Back to rankings

2 hedge funds and large institutions have $124K invested in ZyVersa Therapeutics in 2022 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 29 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
2
Holders Change
-27
Holders Change %
-93.1%
% of All Funds
0.03%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
2
Increased
–
Reduced
–
Closed
29
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Goldman Sachs
Goldman Sachs
New York
$101K
2
CL
CSS LLC
Illinois
$23K

Top Sellers

1
RA
RiverPark Advisors
New York
$0
2
Hudson Bay Capital Management
Hudson Bay Capital Management
Connecticut
$0
3
CM
Cohanzick Management
New York
$0
4
SCM
Saba Capital Management
New York
$0
5
YCM
Yakira Capital Management
Connecticut
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
EFI
26
EHP Funds Inc
Canada
– -$171K -49 Closed
WAM
27
Warberg Asset Management
Illinois
– -$120K -34 Closed
BlackRock
28
BlackRock
New York
– -$50K -14 Closed
AA
29
Ancora Advisors
Ohio
– -$20K -6 Closed
EC
30
Elequin Capital
New York
– -$10K -3 Closed
CS
31
Clear Street
New York
– -$4K -1 Closed
1
2